Cargando…
Chronic natriuretic peptide protein therapeutics
Autores principales: | Chen, Horng H, Cataliotti, Alessandro, Burnett, John C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765640/ https://www.ncbi.nlm.nih.gov/pubmed/24517645 http://dx.doi.org/10.1186/2050-6511-14-S1-O1 |
Ejemplares similares
-
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013) -
Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties
por: Chen, Horng H, et al.
Publicado: (2009) -
Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009) -
Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011) -
The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation
por: Schirger, John A, et al.
Publicado: (2009)